glp-1 agonists medications list Costs Explained: Managing Coverage Challenges Discovery of GLP-1–Based Drugs for

Diabetes Obes Metab 18(9):936940

These combined mechanisms underpin their efficacy for both weight reduction and cardiometabolic protection ( In recent years, the remarkable efficacy of tirzepatide, a dual GIP/GLP-1 receptor agonist, has emerged ( However, these benefits are accompanied by concerns about side effects, cost, long-term sustainability and, above all, the loss of lean mass, which may be mitigated by concurrent exercise ( Exercise and lifestyle interventions remain foundational for obesity and metabolic disease management, offering broad health benefits, but are often limited by adherence and modest long-term weight loss ( Recent randomized controlled trials and meta-analyses suggest that combining GLP-1RAs with exercise may yield additive or synergistic effects on weight loss and metabolic syndrome severity as well as on oxidative stress and inflammation

Neuroscience 303 , 4250 (2015)

This does not mean semaglutide is an antidepressant

If the primary goal is glucose management, Ozempic may be ideal